首页 › 基金 › SEB Asset Management AB › COR

SEB Asset Management AB 对 COR 的持仓历史

CENCORA INC · 医疗保健

SEB Asset Management AB 在 Q2 2026 的 13F 申报中披露持有 COR(CENCORA INC)367,624 股,市值约 US$104.0M,约占其申报组合的 0.39%,在其申报持仓中市值排名第 43 位。 SEB Asset Management AB 最近 2 个申报季度中有 2 个季度披露了 COR 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q2 2026)367.62K 股
申报持仓市值$104.03M
组合权重0.39%
首次申报Q1 2026
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

SEB Asset Management AB 对 COR 的持仓演变

SEB Asset Management AB 于 Q1 2026 首次披露 COR 持仓:427,004 股(约 US$134.1M)。 在 2 次申报中,SEB Asset Management AB 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 367,624 股、市值约 US$104.0M,环比减持 -59,380 股。。

逐季持仓明细

季度股数金额变化
Q1 2026 427.00K $134.14M 新进
Q2 2026 367.62K $104.03M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 COR 与 13F 数据

COR(CENCORA INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 COR,申报仓位最大的包括:T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.38B), Carmignac Gestion (US$494.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 COR 的基金

查看 COR 的全部基金持有人 →

常见问题

How long has SEB Asset Management AB held COR?

SEB Asset Management AB has disclosed COR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is SEB Asset Management AB's current position in COR?

As of Q2 2026, SEB Asset Management AB holds 367.62K shares of COR (CENCORA INC), valued at $104.03M, representing 0.39% of its reported portfolio and ranking #43.

Has SEB Asset Management AB been buying or selling COR?

In the latest 13F filing (Q2 2026), SEB Asset Management AB reduced its position in COR.

Which other funds hold COR?

Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Carmignac Gestion, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.